Robert Gibbons to Drug Labeling
This is a "connection" page, showing publications Robert Gibbons has written about Drug Labeling.
Connection Strength
0.169
-
Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Saf. 2011 Jul 01; 34(7):533-44.
Score: 0.096
-
Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007 Sep; 164(9):1356-63.
Score: 0.073